Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease

References

• Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008;118:3546–3556.
   PubMed Web of Science ®Google Scholar
• Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and copd. Clin Respir J 2013;7:342–346.
   PubMed Web of Science ®Google Scholar
• Kim SR, Rhee YK. Overlap between asthma and copd: where the two diseases converge? Allergy Asthma Immunol Res 2010;2:209–214.
   PubMed Web of Science ®Google Scholar
• Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218–224.
   PubMed Web of Science ®Google Scholar
• Cianchetti S, Bacci E, Ruocco L, Pavia T, Bartoli ML, Cardini C, Costa F, et al. Are sputum eosinophil cationic protein and eosinophils differently associated with clinical and functional findings of asthma? Clin Exp Allergy 2014;44:673–680.
   PubMed Web of Science ®Google Scholar
• Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care. J Allergy Clin Immunol 2015;135:299–310.
   PubMed Web of Science ®Google Scholar
• Lee CG, Elias JA. Role of breast regression protein-39/ykl-40 in asthma and allergic responses. Allergy Asthma Immunol Res 2010;2:20–27.
   PubMed Web of Science ®Google Scholar
• Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007;357:2016–2027.
   PubMed Web of Science ®Google Scholar
• Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da Silva CA, Sohn MH, et al. Role of breast regression protein 39 (brp-39)/chitinase 3-like-1 in th2 and il-13-induced tissue responses and apoptosis. J Exp Med 2009;206:1149–1166.
   PubMed Web of Science ®Google Scholar
• Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, et al. Ykl-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 2008;181:5167–5173.
   PubMed Web of Science ®Google Scholar
• Sohn MH, Kang MJ, Matsuura H, Bhandari V, Chen NY, Lee CG, Elias JA. The chitinase-like proteins breast regression protein-39 and ykl-40 regulate hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2010;182:918–928.
   PubMed Web of Science ®Google Scholar
• Matsuura H, Hartl D, Kang MJ, Dela Cruz CS, Koller B, Chupp GL, Homer RJ, et al. Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema. Am J Respir Cell Mol Biol 2011;44:777–786.
   PubMed Web of Science ®Google Scholar
• Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365:1088–1098.
   PubMed Web of Science ®Google Scholar
• Tsicopoulos A, Chang Y, Ait Yahia S, de Nadai P, Chenivesse C. Role of ccl18 in asthma and lung immunity. Clin Exp Allergy 2013;43:716–722.
   PubMed Web of Science ®Google Scholar
• Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Connett JE, et al. Serum parc/ccl-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183:1187–1192.
   PubMed Web of Science ®Google Scholar
• Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, Olschewski M, et al. Serum cc-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009;179:717–723.
   PubMed Web of Science ®Google Scholar
• Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the american thoracic society was adopted by the ats board of directors, july 1999. Am J Respir Crit Care Med 2000;161:309–329.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, et al. Changes in forced expiratory volume in 1 second over time in copd. N Engl J Med 2011;365:1184–1192.
   PubMed Web of Science ®Google Scholar
• Standardization of spirometry, 1994 update. American thoracic society. Am J Respir Crit Care Med 1995;152:1107–1136.
   Google Scholar
• Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981;2:93–113.
   PubMedGoogle Scholar
• Konradsen JR, James A, Nordlund B, Reinius LE, Soderhall C, Melen E, Wheelock AM, et al. The chitinase-like protein ykl-40: A possible biomarker of inflammation and airway remodeling in severe pediatric asthma. J Allergy Clin Immunol 2013;132:328–335, e325.
   PubMed Web of Science ®Google Scholar
• Rufo J, Taborda-Barata L, Lourenco O. Serum biomarkers in elderly asthma. J Asthma 2013;50:1011–1019.
   PubMed Web of Science ®Google Scholar
• Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, Muller SJ, Fahy JV. Roles of epithelial cell-derived periostin in tgf-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 2010;107:14170–14175.
   PubMed Web of Science ®Google Scholar
• Kim HB, Kim CK, Iijima K, Kobayashi T, Kita H. Protein microarray analysis in patients with asthma: elevation of the chemokine parc/ccl18 in sputum. Chest 2009;135:295–302.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98–114.
   PubMed Web of Science ®Google Scholar
• Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, Kawayama T, Kato S, et al. Interleukin-18 production and pulmonary function in copd. Eur Respir J 2008;31:287–297.
   PubMed Web of Science ®Google Scholar
• Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M. Ifn-gamma-inducing factor (igif) is a costimulatory factor on the activation of th1 but not th2 cells and exerts its effect independently of il-12. J Immunol 1997;158:1541–1550.
   PubMed Web of Science ®Google Scholar
• Kurt E, Aktas A, Aksu K, Keren M, Dokumacioglu A, Goss CH, Alatas O. Autologous serum skin test response in chronic spontaneous urticaria and respiratory diseases and its relationship with serum interleukin-18 level. Arch Dermatol Res 2011;303:643–649.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Miyazaki N, Oashi K, Teramoto S, Shiratori M, Hashimoto M, Ohmichi M, Abe S. Il-18 might reflect disease activity in mild and moderate asthma exacerbation. J Allergy Clin Immunol 2001;107:331–336.
   PubMed Web of Science ®Google Scholar
• Verhaeghe B, Gevaert P, Holtappels G, Lukat KF, Lange B, Van Cauwenberge P, Bachert C. Up-regulation of il-18 in allergic rhinitis. Allergy 2002;57:825–830.
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Tang H, Fang Z, Sun Y, Li B, Shi Z, Chen J, Zhang T, Xiu Q. Ykl-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin e. Eur Respir J 2010;35:757–760.
   PubMed Web of Science ®Google Scholar
• Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, et al, Bronchoscopic Exploratory Research Study of Biomarkers in Corticosteroid-refractory Asthma Study G. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012;130:647–654, e610.
   PubMed Web of Science ®Google Scholar
• Ando M, Shima M. Serum interleukins 12 and 18 and immunoglobulin e concentrations and allergic symptoms in japanese schoolchildren. J Investig Allergol Clin Immunol 2007;17:14–19.
   PubMed Web of Science ®Google Scholar